Journal
STEM CELLS AND DEVELOPMENT
Volume 15, Issue 3, Pages 381-389Publisher
MARY ANN LIEBERT INC
DOI: 10.1089/scd.2006.15.381
Keywords
-
Funding
- NATIONAL INSTITUTE ON AGING [R01AG023472] Funding Source: NIH RePORTER
- NIA NIH HHS [R01AG 23472] Funding Source: Medline
Ask authors/readers for more resources
Although amyloid beta(A beta) deposition has been a hallmark of Alzheimer's disease (AD), the absence of a phenotype in the beta amyloid precursor protein (APP) knockout mouse, tends to detract our attention away from the physiological functions of APP. Although much attention has been focused on the neurotoxicity of A beta, many studies suggest the involvement of APP in neuroplasticity. We found that secreted amyloid precursor protein ( sAPP) increased the differentiation of human neural stem cells (hNSCs) in vitro, while an antibody-recognizing APP dose-dependently inhibited these activities. With a high dose of sAPP treatment or wild-type APP gene transfection, hNSCs were differentiated into astrocytes rather than neurons. In vivo, hNSCs transplanted into APP-transgenic mouse brain exhibited glial differentiation rather than neural differentiation. Our results suggest that APP regulates neural stem cell biology in the adult brain, and that altered APP metabolism in Down syndrome or AD may have implications for the pathophysiology of these diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available